The way property values are displayed:
The way concept relations are shown:
The way concept relations are shown:
Immunotherapy, Active
Hierarchy: | ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active 5 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active 5 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active 5 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active 5 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active 5 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active 5 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active 5 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active 5 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active 5 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active 5 coordinate concepts1 subordinate concept∟ ∟ ∟ ∟ ∟ |
Broader terms: | ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active ∟ ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active ∟ ∟ ∟ ∟ Immunotherapy, Active ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active ∟ ∟ ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active ∟ ∟ ∟ ∟ ∟ Immunotherapy, Active |
Narrower terms: | |
Annotation: | IM; do not use /util except by MeSH definition
X |
History note: | Immunotherapy (1967-1990)X |
historyNote*: | 91; IMMUNE RNA MANIPULATION was see IMMUNIZATION, PASSIVE 1983-96; VACCINE THERAPY was see IMMUNOTHERAPY 1990, was heading 1963-82
X |
onlineNote*: | use IMMUNIZATION, PASSIVE to search IMMUNE RNA MANIPULATION 1983-96; use IMMUNOTHERAPY to search VACCINE THERAPY 1990
X |
publicMeSHNote*: | 91; IMMUNE RNA MANIPULATION was see IMMUNIZATION, PASSIVE 1983-96; VACCINE THERAPY was see IMMUNOTHERAPY 1990, was heading 1963-82
X |
Scope note: | Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system.
X |
activeMeSHYear*: | |
dateCreated*: | 1990-05-07X |
dateEstablished*: | 1991-01-01X |
dateRevised*: | 1996-06-10X |
recordAuthorizer*: | PLSX |
recordMaintainer*: | AGSX |
recordOriginator*: | AGSX |
Type: | |
Coordinate terms: | |
URI: | |
Labels and equivalent concepts: | Aktiivinen immunoterapia (fi) XImmunterapi, aktiv (sv) Therapy, Vaccine (en, replaced) Active Immunotherapy (en, replaced) |
Share: |
Loading results...